Here are a few comments for your consideration:
a)Yes, according to the company policy the payout ratio is between 50% and 80%, so the maximum "error" in the payment can be 8/5=1.6
b)In reality for the past several years since FY19 the payout ratio has not been below 70%, so the above mentioned error is reduced to 8/7=1.14 or only 14%only.
c)Now we will take into a consideration an error made by PilbaraBoy with a statement of “FMG receive approx 85-90%”. As per the information from http://www.custeel.com/en/csi.jspwe have that the average 62% Fe fines IOP since 1 January 2022 has been ~US$142.
A full production cost in the past was ~US$41. So based on the 70% (from recent company reports) and 90% (from PilbaraBoy post) rates we have the following figures for the profit:
70% => US$99.4-US$41=US$58.4
90% => US$127.8-US$41=US$86.7
86.7/58.4>1.48 or over 48% error
So in summary as you can see an error in the rate for the IOP for 62% Fe is significantly larger that an error in the realistic payout ratio.
- Forums
- ASX - By Stock
- FMG
- next dividend
next dividend, page-58
-
- There are more pages in this discussion • 185 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FMG (ASX) to my watchlist
(20min delay)
|
|||||
Last
$18.28 |
Change
0.140(0.77%) |
Mkt cap ! $55.94B |
Open | High | Low | Value | Volume |
$18.14 | $18.38 | $18.02 | $91.40M | 5.026M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
25 | 5550 | $18.27 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.28 | 1117 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
26 | 9106 | 18.310 |
16 | 8111 | 18.300 |
12 | 6271 | 18.290 |
10 | 6299 | 18.280 |
10 | 7869 | 18.270 |
Price($) | Vol. | No. |
---|---|---|
18.330 | 6562 | 11 |
18.340 | 9158 | 16 |
18.350 | 8598 | 15 |
18.360 | 9244 | 15 |
18.370 | 8843 | 13 |
Last trade - 14.55pm 13/11/2024 (20 minute delay) ? |
Featured News
FMG (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online